{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antidiabetic drugs", "DPP-IV inhibitors.", "hypoglycemic action", "inhibitory activity", "machine learning", "mechanism of action"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34161205", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1381612827666210622104428"], "Journal": {"ISSN": "1873-4286", "JournalIssue": {"Volume": "28", "Issue": "4", "PubDate": {"Year": "2022"}}, "Title": "Current pharmaceutical design", "ISOAbbreviation": "Curr Pharm Des"}, "ArticleTitle": "Application of Machine Learning Methods for the Development of Antidiabetic Drugs.", "Pagination": {"StartPage": "260", "EndPage": "271", "MedlinePgn": "260-271"}, "Abstract": {"AbstractText": ["Diabetes is a chronic non-communicable disease caused by several different routes, which has attracted increasing attention. In order to speed up the development of new selective drugs, machine learning (ML) technology has been applied in the process of diabetes drug development and opens up a new blueprint for drug design. This review provides a comprehensive portrayal of the application of ML in antidiabetic drug use."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Sciences, Shanghai University, 200444,China."}], "LastName": "Zhao", "ForeName": "Juanjuan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Materials Genome Institute, Shanghai University, Shanghai 200444,China."}], "LastName": "Xu", "ForeName": "Pengcheng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Sciences, Shanghai University, 200444,China."}], "LastName": "Liu", "ForeName": "Xiujuan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Sciences, Shanghai University, 200444,China."}], "LastName": "Ji", "ForeName": "Xiaobo", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Sciences, Shanghai University, 200444,China."}], "LastName": "Li", "ForeName": "Minjie", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynaecology, Imperial College London, Fulham Road, London SW10 9 NH,United Kingdom."}], "LastName": "Sooranna", "ForeName": "Dev", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Laboratory of Southwest Endangered Medicinal Resources Development, Guangxi Botanical Garden of Medicinal Plants, No. 189, Changgang Road, 530023, Nanning,China."}], "LastName": "Qu", "ForeName": "Xiaosheng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, College of Sciences, Shanghai University, 200444,China."}], "LastName": "Lu", "ForeName": "Wencong", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Shanghai University, 200444,China."}], "LastName": "Niu", "ForeName": "Bing", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Pharm Des", "NlmUniqueID": "9602487", "ISSNLinking": "1381-6128"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dipeptidyl-Peptidase IV Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Dipeptidyl-Peptidase IV Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Machine Learning"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "11", "Day": "26"}, {"Year": "2021", "Month": "5", "Day": "10"}, {"Year": "2021", "Month": "6", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "23", "Hour": "17", "Minute": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34161205", "10.2174/1381612827666210622104428", "CPD-EPUB-116267"]}}], "PubmedBookArticle": []}